Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Estrogen is a steroid hormone that plays a central role in the regulation of the female reproductive system and is known to have significant effects on the cardiovascular system. In the clinical trial Estrogen, Cytokines and Heart Failure in Women (NCT00000608), sponsored by the National Heart, Lung, and Blood Institute (NHLBI), estrogen was evaluated as a potential treatment for postmenopausal women with idiopathic dilated cardiomyopathy (IDCM). The study aimed to determine if estrogen replacement therapy could improve heart failure symptoms, promote reverse ventricular remodeling, and decrease the levels of pro-inflammatory cytokines, which are associated with the progression of heart failure. Estrogen's mechanism of action involves binding to estrogen receptors alpha (ERα) and beta (ERβ), which then modulate the transcription of genes involved in vascular tone, inflammation, and myocardial cell survival.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on estrogen.